PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
There is no evidence from clinical studies that ipecac improves the outcome of poisoned patients; its routine administration should be abandoned [PMID:15214617, PMID:23406298].
Emetine, an active component of ipecac, exhibits antihelminthic and antiamoebic properties [PMID:28846272].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 28846272 (2026) — Ipecacuanha. · Archives of emergency medicine
- 2.PMID: 15214617 (2004) — Position paper: Ipecac syrup. · Journal of toxicology. Clinical toxicology
- 3.PMID: 34308635 (2021) — Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling. · Journal of natural products
- 4.PMID: 1349315 (1992) — Ipecac abuse--danger. · Journal of American college health : J of ACH
- 5.PMID: 239305 (1975) — ipecacuanha-ipecauanha. · The Medical journal of Australia
- 6.